We have all seen expensive gym memberships and exclusive wellness retreats, but would you pay a million dollars a year to have a computer tell you how to live forever? That is the question posed by the latest venture from Bryan Johnson, the tech centimillionaire who famously spends millions on his own body to reverse his biological age.
After years of treating his body as a singular science experiment—known as Project Blueprint—Johnson is officially opening the doors to others. But the entry fee is steep. According to recent reports, Johnson’s new "Immortals" program comes with a $1 million annual price tag, effectively creating an ultra-luxury tier in the burgeoning longevity market.
This isn’t just about buying supplements or getting a personal trainer. This is Johnson attempting to scale his extreme quantified-self lifestyle into a commercial product, betting that AI is the missing link between human biology and radical life extension.
What do you actually get for $1 million a year?
If you are one of the lucky few to snag a spot—Johnson is reportedly limiting the initial intake to just three people—you aren’t just getting a diet plan. The "Immortals" program is designed as a comprehensive overhaul of your biological existence.
The core of the offering is 24/7 access to "BryanAI," an artificial intelligence companion designed to synthesize millions of biomarker data points. The promise here is real-time health guidance based on the same rigorous standards Johnson applies to himself. Subscribers also receive a dedicated concierge team to handle the logistics of radical life extension.
Beyond the digital assistance, the program includes extensive medical imaging and lab work. Perhaps most intriguingly for biohackers, it offers the exact skin, hair, and therapy protocols that Johnson uses. This is a pivot from what industry observers call "n=1" experiments (where the sample size is just one person) to a slightly broader, albeit exclusive, application of his methodology.
How does ‘BryanAI’ fit into the longevity equation?
The introduction of BryanAI is arguably the most significant part of this announcement. Johnson has previously signaled that he believes AI innovation makes "immortality by 2039" a realistic target. By integrating an AI assistant, the program moves beyond static doctor visits into continuous monitoring.
The concept is that an AI can process the complex web of biological data—from sleep metrics to blood panels—faster and more accurately than a human team alone. It represents a shift from health data being a "public hobby," as described by The Meridiem, to a personalized, exclusive service. Johnson is betting that the only way to manage the sheer volume of data required to slow aging is through advanced computation.
Is this just for billionaires, or is there a plan for the rest of us?
While the headline is the seven-figure price tag, there is a hint of democratization on the horizon. Johnson has signaled a future "supported" tier priced in the mid-five figures. While tens of thousands of dollars is still a significant investment, it is a far cry from the $1 million flagship offering.
This tiered approach suggests that the "Immortals" program is the tip of the spear—a way to fund and refine the high-touch protocols before rolling out a more scalable version. Blueprint has already expanded its product line to include sub-$100 consumer goods like supplements and olive oil, creating an ecosystem that ranges from accessible pantry items to this ultra-premium service.
How does this compare to the competition?
To understand the audacity of this pricing, you have to look at the current market. Competitors like Fountain Life charge around $21,500 annually, while Biograph sits near $15,000. Johnson’s program isn’t just slightly more expensive; it dwarfs the competition, establishing a new ceiling for the longevity sector.
This $1 million price point signals a transition for the industry. We are moving from niche biohacking communities into a formalized, high-stakes industry where health data is monetized as a luxury concierge service. Johnson is effectively claiming that his specific methodology—and the AI built upon it—is worth 50 times more than the standard premium longevity clinic.
Why It Matters
The launch of the Immortals program is a critical moment for the health tech industry because it validates the "health-as-a-service" business model at the highest possible level. While the $1 million price tag grabs headlines, the real story is the data aggregation: Johnson is using the ultra-wealthy to train an AI model (BryanAI) that could eventually become a mass-market product. High-net-worth individuals get early access to extreme life extension protocols, but the long-term winner is the algorithm itself, which gets smarter with every wealthy guinea pig it analyzes. This moves longevity from a passive medical hope to an active, engineering problem solved by capital and code.